ProSanos Corporation Releases New Software System to Improve Patient
Safety via Surveillance and Analysis of Claims and Electronic Health
Records
HARRISBURG, Pa. (Business Wire EON/PRWEB ) August 12, 2008 --
ProSanos Corporation announced today the release of SÆfetyworks™,
a web-based, semi-automated software system that can help scientists
more quickly spot and measure the strength of associations between a
drug and a medical condition found within large electronic healthcare
databases. SÆfetyworks™
resulted from a partnership between GlaxoSmithKline plc (GSK) and
ProSanos. Several years in development, it is now available to all
pharmacovigilance professionals.
The new software system, pioneered by GSK and ProSanos, is an efficient
way to perform active drug surveillance and complement traditional
epidemiologic studies. Using SÆfetyworks™,
drug safety experts will have the unprecedented ability to ask the same
questions of different databases. Data from traditional sources, like
adverse event reports and epidemiological studies, can quickly and
reliably be compared with information from observational sources like
insurance claims and electronic medical records. In addition,
pharmacovigilance professionals will be able to control for multiple
confounding factors, helping them to quickly distinguish unusual
conditions that may be associated with a drug from conditions that are
disease-related or limited to specific cohorts of patients.
Commenting on the co-development collaboration with ProSanos, Edward
Pattishall, MD, VP Safety at GSK stated, “GSK
is committed to enhancing patient safety and anticipates this tool will
be extremely helpful in evaluating the benefit/risk profile of our
medicines using multiple data sources that can’t
currently be easily and quickly compared.
It is an improvement over other software solutions because it can
rapidly and simultaneously interrogate multiple databases and contribute
to the evidence of a potential safety issue. We have made an up-front
investment in developing this tool and we hope that others will benefit
as enhancing patient safety is a common goal for everyone involved in
the manufacture, administration and regulation of medicines.”
Jonathan Morris, M.D., President and CEO of ProSanos Corporation, said, “In
a post-market environment, robust well-designed technologies like SÆfetyworks™
can be an important part of the solution to the challenges of drug
safety surveillance. ProSanos looks forward to deploying the system with
other participants in the process, so that even larger numbers of
patients might benefit.”
About ProSanos Corporation
The mission of ProSanos Corporation (www.prosanos.com)
is to advance patient safety and care by providing clients and partners
with superior products and services for the integration, analysis and
management of healthcare-related data. Founded in 2000 and known for its
innovative approach to the analysis and mining of healthcare data, the
company provides products and services that promote in-depth
understanding of the treatment of specific diseases and conditions.
ProSanos Corporation is headquartered in Harrisburg, PA.
See the original story at: http://eon.businesswire.com/releases/prosanos/corporation/prweb1203364.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1aZXRhLVN1bW0tSGFsZi1Db3VwLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
